Insurer Lost Millions In Regeneron Drug Scheme, Suit Says
Pharmaceutical company Regeneron raked in ill-gotten gains by making charitable donations to offset the price patients paid for a vision loss drug — all while insurers remained on the hook for...To view the full article, register now.
Already a subscriber? Click here to view full article